Table 5
|
| Simulations of substrate availability: cardiomyocyte target function |
| βGlucose |
βPalmitate |
βStearate |
βOleate |
βα−Linoleate |
βEPA |
βDHA |
βAcetoacetate |
βLactate |
 |
vs |
vGL |
vGS |
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|
| 0.9000 |
0.0500 |
0.0000 |
0.0000 |
0.0167 |
0.0167 |
0.0167 |
0.0000 |
0.0000 |
6.9154 |
4.8859 |
0.0000 |
0.4027 |
0.8438 |
| 0.2500 |
0.0000 |
0.0000 |
0.0000 |
0.2083 |
0.0000 |
0.0417 |
0.0000 |
0.5000 |
4.0502 |
0.4093 |
0.1450 |
0.0000 |
0.8000 |
| 0.4500 |
0.0417 |
0.0000 |
0.0000 |
0.0417 |
0.0000 |
0.1667 |
0.3000 |
0.0000 |
11.4761 |
2.0466 |
0.0000 |
0.0000 |
0.7500 |
| 0.2500 |
0.0250 |
0.0000 |
0.0500 |
0.0250 |
0.0250 |
0.0250 |
0.5500 |
0.0500 |
14.9112 |
3.2573 |
0.0000 |
0.0690 |
0.7000 |
| 0.0000 |
0.0250 |
0.0000 |
0.0250 |
0.0250 |
0.0000 |
0.0750 |
0.1000 |
0.7500 |
17.3465 |
3.4111 |
0.0098 |
0.0000 |
0.6500 |
| 0.2500 |
0.0167 |
0.0167 |
0.0000 |
0.0167 |
0.0167 |
0.0333 |
0.6500 |
0.0000 |
20.2825 |
4.8859 |
0.0000 |
0.1150 |
0.6000 |
| 0.0500 |
0.0000 |
0.0333 |
0.0000 |
0.0167 |
0.0333 |
0.0167 |
0.4500 |
0.4000 |
22.5428 |
4.8859 |
0.0000 |
0.0103 |
0.5500 |
| 0.1500 |
0.0000 |
0.2250 |
0.0750 |
0.0750 |
0.0000 |
0.0750 |
0.1500 |
0.2500 |
25.2571 |
10.2332 |
0.0000 |
0.4532 |
0.5000 |
| 0.4000 |
0.0000 |
0.0167 |
0.0000 |
0.0083 |
0.0083 |
0.0167 |
0.3500 |
0.2000 |
27.6323 |
9.7718 |
0.0000 |
0.3434 |
0.4500 |
| 0.3000 |
0.0000 |
0.0000 |
0.0083 |
0.0083 |
0.0000 |
0.0333 |
0.0500 |
0.6000 |
29.8822 |
10.2332 |
0.0000 |
0.2629 |
0.4000 |
| 0.2500 |
0.0167 |
0.0083 |
0.0000 |
0.0083 |
0.0000 |
0.0167 |
0.3000 |
0.4000 |
32.3227 |
10.2332 |
0.0000 |
0.2266 |
0.3500 |
| 0.2500 |
0.0083 |
0.0083 |
0.0000 |
0.0083 |
0.0000 |
0.0250 |
0.5000 |
0.2000 |
34.8810 |
10.2332 |
0.0000 |
0.2266 |
0.3000 |
| 0.2000 |
0.0000 |
0.0250 |
0.0000 |
0.0083 |
0.0083 |
0.0083 |
0.7500 |
0.0000 |
37.2907 |
9.7718 |
0.0000 |
0.1757 |
0.2500 |
| 0.0000 |
0.0000 |
0.0083 |
0.0083 |
0.0083 |
0.0083 |
0.0167 |
0.3000 |
0.6500 |
38.8292 |
9.7718 |
0.2160 |
0.0000 |
0.2000 |
| 0.0000 |
0.0083 |
0.0083 |
0.0083 |
0.0083 |
0.0000 |
0.0167 |
0.4000 |
0.5500 |
41.2341 |
10.2332 |
0.2160 |
0.0000 |
0.1500 |
| 0.0000 |
0.0167 |
0.0000 |
0.0000 |
0.0083 |
0.0167 |
0.0083 |
0.9500 |
0.0000 |
44.3334 |
9.7718 |
0.0000 |
0.0029 |
0.1000 |
| 0.0000 |
0.0000 |
0.0083 |
0.0000 |
0.0083 |
0.0000 |
0.0333 |
0.9000 |
0.0500 |
47.5569 |
10.2332 |
0.0120 |
0.0000 |
0.0500 |
| 0.0000 |
0.0083 |
0.0000 |
0.0000 |
0.0083 |
0.0000 |
0.0333 |
0.9500 |
0.0000 |
47.9063 |
10.2332 |
0.2160 |
0.0000 |
0.0100 |
Results are shown for simulations of varied substrate availability of glucose, acetoactate,
lactate and 6 different fatty aicids: palmitate, stearate, oleate, alpha-linoleate,
eicosapentaenoate and docosahexaenoate. For each simulated composition efficiency
values
were calculated based on three criteria qj (j=1,2,..,nj): (1) oxygen requirement (
, q1) , (2) total substrate uptake rate (vs, q2) and (3) endogenous glucose dervied
from
glycogenolysis (vGL, q3). Results are ranked by the calculated efficiency
in descending order and given for maximal and minimal calculated efficiency values.
Further results are shown for each efficiency value of 0.3, 0.35,
0.4, 0.45, 0.5, 0.55, 0.6, 0.65. Rates for oxygen requirement (
), total substrate uptake rates (vs), glycogenolysis (vGL) and glycogen synthesis (vGS) are given in mmol ⋅ min−1 ⋅ (l cell)−1. For a complete overview of all results,
please see Additional file 11 and 12. GL indicates glycogenolysis; GS, glycogen synthesis; EPA, eicosapentaenoate; and
DHA, docosahexaenoate.
Karlstädt et al. BMC Systems Biology 2012 6:114 doi:10.1186/1752-0509-6-114